Dr. Kai W. Wucherpfennig is Chair of Cancer Immunology and Virology, and Director of the Center for Cancer Immunotherapy Research at Dana-Farber Cancer Institute. He is the Nancy Lurie Marks Professor of Neurology in the Field of Medical Oncology; Professor of Neurology at Brigham and Women’s Hospital and Harvard Medical School; a Professor of Immunology at Harvard Medical School; and an Associate Member of Broad Institute of MIT and Harvard.
Dr. Wucherpfennig is an elected fellow, American Society for the Advancement of Science; an elected member of American Society for Clinical Investigation; an elected member, Henry Kunkel Society, Rockefeller University.
Dr. Wucherpfennig received his MD in 1986 and his PhD in 1987 from the University of Goettingen, Germany. He completed research fellowships at Brigham and Women’s Hospital and the Department of Molecular and Cellular Biology, Harvard University. In 1995, he joined Dana-Farber Cancer Institute, where he is principally involved in basic laboratory research that focuses on T cell immunology and the role of T cells in cancer immunology.